PROGNOSTIC SIGNIFICANCE OF TONSL EXPRESSION AND THE HOMOLOGOUS RECOMBINATION PATHWAY IN INTERMEDIATE-RISK PROSTATE CANCER RECURRENCE

被引：0
|
作者：
So, Jonathan [1 ]
Chua, Melvin [2 ]
Lalonde, Emilie [3 ]
Mahamud, Osman [1 ]
Berlin, Alejandro [1 ]
Dal Pra, Alan [4 ]
Orain, Michele [5 ]
Hovington, Helene [6 ]
Bergeron, Alain [6 ]
Fradet, Yves [6 ]
Tetu, Bernard [5 ]
Meng, Alice [2 ]
Zhang, Junyan [2 ]
Zafarana, Gaetano [2 ]
Pintilie, Melania [2 ]
van der Kwast, Theodorus [1 ]
Fraser, Michael [2 ]
Boutros, Paul [2 ]
Bristow, Robert G. [2 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] Ontario Inst Canc Res, Toronto, ON, Canada
[4] Univ Bern, Bern, Switzerland
[5] CHUQ, Quebec City, PQ, Canada
[6] Univ Laval, Quebec City, PQ, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2016年 / 120卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
227
引用
收藏
页码：S82 / S83
页数：2
相关论文
共 50 条
  • [1] Prognostic Significance of Tonsil Expression and the Homologous Recombination Pathway in Intermediate-Risk Prostate Cancer Recurrence
    So, J.
    Chua, M. L. K.
    Lalonde, E.
    Dal Pra, A.
    Berlin, A.
    Orain, M.
    Hovington, H.
    Bergeron, A.
    Fradet, Y.
    Tetu, B.
    Meng, A.
    Zhang, J.
    Zafarana, G.
    Livingstone, J.
    Pintilie, M.
    van der Kwast, T.
    Fraser, M.
    Boutros, P. C.
    Bristow, R. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S113 - S113
  • [2] The Prognostic Significance of Homologous Recombination Repair Pathway Alterations in Metastatic Hormone Sensitive Prostate Cancer
    Lee, Aaron M.
    Saidian, Ava
    Shaya, Justin
    Nonato, Taylor
    Cabal, Angelo
    Randall, J. Michael
    Millard, Frederick
    Stewart, Tyler
    Rose, Brent
    Tamayo, Pablo
    McKay, Rana R.
    CLINICAL GENITOURINARY CANCER, 2022, 20 (06) : 515 - 523
  • [3] The risk of biochemical recurrence for intermediate-risk prostate cancer after radical prostatectomy
    Kurbegovic, Sorel
    Berg, Kasper Drimer
    Thomsen, Frederik Birkebaek
    Gruschy, Lisa
    Iversen, Peter
    Brasso, Klaus
    Roder, Martin Andreas
    SCANDINAVIAN JOURNAL OF UROLOGY, 2017, 51 (06) : 450 - 456
  • [4] Prognostic Value of the Intermediate-risk Feature in Men with Favorable Intermediate-risk Prostate Cancer: Implications for Active Surveillance
    Sherer, Michael, V
    Leonard, Austin J.
    Nelson, Tyler J.
    Guram, Kripa
    De Moraes, Gustavo Rodrigues
    Javier-Desloges, Juan
    Kane, Christopher
    McKay, Rana R.
    Rose, Brent S.
    Bagrodia, Aditya
    EUROPEAN UROLOGY OPEN SCIENCE, 2023, 50 : 61 - 67
  • [5] Prognostic significance of the mEPE score in intermediate-risk prostate cancer patients undergoing ultrahypofractionated robotic SBRT
    Mose, Lucas
    Loebelenz, Laura Isabel
    Althaus, Alexander
    Ahmadsei, Maiwand
    Mathier, Etienne
    Broemel, Isabelle
    Aebersold, Daniel M.
    Obmann, Verena Carola
    Shelan, Mohamed
    STRAHLENTHERAPIE UND ONKOLOGIE, 2025,
  • [6] Prognostic and therapeutic impact of a homologous recombination repair protein TONSL in cancer stem cells
    Lee, Hani
    Choi, SeokGyeong
    Ha, Sojung
    Kim, Woo-Young
    CANCER RESEARCH, 2023, 83 (07)
  • [7] The prognostic significance of homologous recombination repair pathway alterations in metastatic hormone-sensitive prostate cancer.
    Shaya, Justin
    Lee, Aaron
    Cabal, Angelo
    Panian, Justine
    Randall, James Michael
    Millard, Frederick E.
    Stewart, Tyler Francis
    Rose, Brent S.
    Parsons, John Kellogg
    McKay, Rana R.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [8] Prognostic value of copy-number alterations of the Cohesin complex in intermediate-risk prostate cancer recurrence.
    So, Jonathan
    Chua, Melvin
    Lalonde, Emilie
    Mahamud, Osman
    Berlin, Alejandro
    Dal Pra, Alan
    Orain, Michele
    Hovington, Helene
    Bergeron, Alain
    Fradet, Yves
    Tetu, Bernard
    Meng, Alice
    Zhang, Junyan
    Zafarana, Gaetano
    Livingstone, Julie
    Pintilie, Melania
    van der Kwast, Theodorus
    Fraser, Michael
    Boutros, Paul
    Bristow, Robert G.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [9] Use of genetic instability to predict biochemical recurrence in intermediate-risk prostate cancer
    Bristow, R. G.
    Ishkanian, A. S.
    Malloff, C.
    Milosevic, M.
    Pintilie, M.
    van der Kwast, T.
    Lam, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [10] A prognostic CNA signature sub-stratifies intermediate-risk prostate cancer
    Boutros, P. C.
    Lalonde, E.
    Ishkanian, A. S.
    Sykes, J.
    Moon, N.
    Zafarana, G.
    Thoms, J.
    Have, C. L.
    Malloff, C.
    Ramnarine, V. R.
    Meng, A.
    Mak, D. F. Y.
    Squire, J.
    Jurisica, I.
    Pintilie, M.
    Dal Pra, A.
    van der Kwast, T.
    Lam, W. L.
    Milosevic, M.
    Bristow, R. G.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S14 - S14
12345